TW201345558A - External preparation for skin - Google Patents

External preparation for skin Download PDF

Info

Publication number
TW201345558A
TW201345558A TW102108994A TW102108994A TW201345558A TW 201345558 A TW201345558 A TW 201345558A TW 102108994 A TW102108994 A TW 102108994A TW 102108994 A TW102108994 A TW 102108994A TW 201345558 A TW201345558 A TW 201345558A
Authority
TW
Taiwan
Prior art keywords
molecular weight
average molecular
number average
external preparation
skin
Prior art date
Application number
TW102108994A
Other languages
Chinese (zh)
Inventor
Hiroaki Ozawa
Sayoko Hasegawa
Yukako Sato
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of TW201345558A publication Critical patent/TW201345558A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24Phosphorous; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0254Platelets; Flakes
    • A61K8/0258Layered structure
    • A61K8/0262Characterized by the central layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The present invention is an external preparation for the skin, which is characterized by containing (A) silver-supporting antibacterial tricalcium phosphate and (B) a polypropylene glycol having a number average molecular weight of 700-4,000, a copolymer of a polypropylene glycol having a number average molecular weight of 700-4,000 and a polybutylene glycol, or a derivative of a polypropylene glycol having a number average molecular weight of 700-4,000. The purpose of the present invention is to provide an external preparation for the skin, which contains a silver-supporting antibacterial tricalcium phosphate powder and is prevented from giving a powdery look caused by the silver-supporting antibacterial tricalcium phosphate powder.

Description

皮膚外用劑 Skin external preparation

本發明係關於一種皮膚外用劑。進一步詳細而言,關於一種調配有擔載有銀之磷酸三鈣粉末,且降低或防止擔載有銀之磷酸三鈣粉末引起之泛白的皮膚外用劑。 The present invention relates to a skin external preparation. More specifically, the present invention relates to a skin external preparation prepared by mixing a tricalcium phosphate powder carrying silver and reducing or preventing the whitening caused by the tricalcium phosphate powder carrying silver.

抗菌性磷酸三鈣之粉末係作為防腐劑或除臭劑而調配至化妝料或準藥品等皮膚外用劑中。 The antibacterial tricalcium phosphate powder is formulated as a preservative or deodorant to an external preparation for skin such as a cosmetic or a quasi-drug.

例如,於專利文獻1中,揭示有調配有抗菌性磷酸三鈣之除臭劑。專利文獻1之課題在於提供一種除臭劑,該除臭劑係去除惡臭並且效率良好地殺死將活體分泌物分解產生惡臭之細菌,另外對活體無害者。然而,於專利文獻1中,並未記載亦未示意關於調配有抗菌性磷酸三鈣之情形時所產生之泛白。 For example, Patent Document 1 discloses a deodorant formulated with an antibacterial tricalcium phosphate. The object of Patent Document 1 is to provide a deodorant which removes malodors and efficiently kills bacteria which decompose the living secretions to produce malodor, and which is harmless to the living body. However, Patent Document 1 does not describe or whiten the whitening which occurs when the antibacterial tricalcium phosphate is formulated.

專利文獻1:日本特開平8-126690號公報 Patent Document 1: Japanese Patent Laid-Open No. Hei 8-126690

另一方面,本發明人等發現調配有擔載有銀之抗菌性磷酸三鈣之皮膚外用劑會產生來自於擔載有銀之抗菌性磷酸三鈣的泛白之問題。 即,若使用調配有擔載有銀之抗菌性磷酸三鈣的皮膚外用劑,則產生於所塗佈之身體部位會有白色顯眼之泛白問題。 On the other hand, the present inventors have found that a skin external preparation containing antibacterial tricalcium phosphate loaded with silver causes a problem of whitening from the antibacterial tricalcium phosphate carrying silver. In other words, when a skin external preparation containing antibacterial tricalcium phosphate loaded with silver is used, there is a problem that whiteness is noticeable in the body part to be coated.

本發明人等鑒於上述觀點,為了防止擔載有銀之抗菌性磷酸 三鈣粉末引起之泛白而潛心研究,結果發現,若於調配有擔載有銀之抗菌性磷酸三鈣粉末的皮膚外用劑中調配數量平均分子量為700~4000之聚丙二醇、數量平均分子量為700~4000之聚丙二醇與聚丁二醇之共聚物、或數量平均分子量為700~4000之聚丙二醇之衍生物,則可獲得塗佈後之白色不顯眼,可降低或防止泛白之皮膚外用劑,從而完成本發明。 In view of the above, the inventors of the present invention have in order to prevent the antibacterial phosphoric acid supported on silver. The tri-calcium powder caused whitening and painstaking research. As a result, it was found that if the skin external preparation containing silver antibacterial tricalcium phosphate powder was formulated, the polypropylene glycol having a number average molecular weight of 700 to 4000 was prepared, and the number average molecular weight was A copolymer of polypropylene glycol and polytetramethylene glycol of 700 to 4000 or a derivative of polypropylene glycol having a number average molecular weight of 700 to 4000 can be used to obtain white color after coating, which can reduce or prevent whitening of the skin. Agent to complete the present invention.

本發明之目的在於提供一種調配有擔載有銀之抗菌性磷酸 三鈣粉末,且降低或防止擔載有銀之抗菌性磷酸三鈣粉末引起之泛白的皮膚外用劑。 The object of the present invention is to provide an antibacterial phosphoric acid loaded with silver A tricalcium powder which reduces or prevents the skin external preparation caused by the antibacterial tricalcium phosphate powder loaded with silver.

即,本發明提供一種皮膚外用劑,含有:(A)擔載有銀之抗菌性磷酸三鈣,及(B)數量平均分子量為700~4000之聚丙二醇、數量平均分子量為700~4000之聚丙二醇與聚丁二醇之共聚物、或數量平均分子量為700~4000之聚丙二醇之衍生物之中的任一者。 That is, the present invention provides a skin external preparation comprising: (A) an antibacterial tricalcium phosphate loaded with silver, and (B) a polypropylene glycol having a number average molecular weight of 700 to 4000, and a number average molecular weight of 700 to 4000. Any of a copolymer of propylene glycol and polytetramethylene glycol or a derivative of polypropylene glycol having a number average molecular weight of 700 to 4,000.

又,本發明提供上述皮膚外用劑,其中上述(B)數量平均分子量為700~4000之聚丙二醇之衍生物為數量平均分子量為700~4000之聚氧丙烯甘油醚、數量平均分子量為700~4000之聚氧丙烯山梨糖醇、數量平均分子量為700~4000之聚氧丙烯丁醚中的任一者。 Further, the present invention provides the above-mentioned external preparation for skin, wherein the (B) derivative of polypropylene glycol having a number average molecular weight of 700 to 4000 is a polyoxypropylene glyceryl ether having a number average molecular weight of 700 to 4000, and a number average molecular weight of 700 to 4000. Any of polyoxypropylene sorbitol and polyoxypropylene butyl ether having a number average molecular weight of 700 to 4,000.

進而,本發明提供上述皮膚外用劑,其相對於皮膚外用劑總量,含有乙醇30質量%以上。 Furthermore, the present invention provides the skin external preparation containing 30% by mass or more of ethanol based on the total amount of the external preparation for skin.

又,本發明提供上述皮膚外用劑,其為液狀化妝料,且為可填充於滾塗式(roll-on)容器中之防臭化妝料。 Moreover, the present invention provides the above-mentioned skin external preparation which is a liquid cosmetic and which is a deodorant cosmetic which can be filled in a roll-on container.

進而,本發明提供上述皮膚外用劑,其為液狀化妝料,且為 可填充於氣溶膠(aerosol)式或分注器(dispenser)式容器中之霧狀防臭化妝料。 Further, the present invention provides the above skin external preparation which is a liquid cosmetic and which is A mist-like deodorant cosmetic that can be filled in an aerosol or dispenser container.

又,本發明提供上述皮膚外用劑,其為液狀化妝料,且為含浸於片材中之片狀防臭化妝料。 Moreover, the present invention provides the above-mentioned skin external preparation which is a liquid cosmetic and which is a sheet-like deodorant cosmetic impregnated into a sheet.

本發明之效果在於在調配有擔載有銀之抗菌性磷酸三鈣粉末之皮膚外用劑中,可降低或防止擔載有銀之抗菌性磷酸三鈣粉末引起之泛白。 The effect of the present invention is to reduce or prevent whitening caused by the antibacterial tricalcium phosphate powder carrying silver in the skin external preparation containing the antibacterial tricalcium phosphate powder loaded with silver.

以下,對本發明進行詳述。 Hereinafter, the present invention will be described in detail.

<(A)擔載有銀之抗菌性磷酸三鈣> <(A) Antibacterial tricalcium phosphate loaded with silver>

本發明中用作(A)成分之擔載有銀之抗菌性磷酸三鈣可使用磷酸三鈣中保持抗菌性銀之磷酸三鈣的粉末。 In the present invention, as the component (A), the antibacterial tricalcium phosphate supported on silver may be a powder of tricalcium phosphate which retains antibacterial silver in tricalcium phosphate.

本發明中可使用市售品(Apacider C:Sangi股份有限公司)。 A commercially available product (Apacider C: Sangi Co., Ltd.) can be used in the present invention.

<(A)擔載有銀之抗菌性磷酸三鈣之調配量> <(A) Formulation amount of antibacterial tricalcium phosphate loaded with silver>

擔載有銀之抗菌性磷酸三鈣之調配量相對於皮膚外用劑總量為0.1~20質量%,較佳為1~10質量%,進而較佳為2~7質量%。可根據製品形態適當決定並調配適當之量。 The amount of the antibacterial tricalcium phosphate supported on the silver is 0.1 to 20% by mass, preferably 1 to 10% by mass, and more preferably 2 to 7% by mass based on the total amount of the external preparation for skin. The appropriate amount can be appropriately determined and formulated according to the form of the product.

「(B)數量平均分子量為700~4000之聚丙二醇、數量平均分子量為700~4000之聚丙二醇與聚丁二醇之共聚物、或數量平均分子量為700~4000之聚丙二醇之衍生物」 "(B) Polypropylene glycol having a number average molecular weight of 700 to 4000, a copolymer of polypropylene glycol and polytetramethylene glycol having a number average molecular weight of 700 to 4000, or a derivative of polypropylene glycol having a number average molecular weight of 700 to 4000"

於本發明中,為降低或防止泛白而調配之(B)成分係如下所述。調配下述(1)~(3)中之一種或兩種以上之(B)成分。 In the present invention, the component (B) formulated to reduce or prevent whitening is as follows. One (2) to (3) or two or more of the components (B) are blended.

(1)數量平均分子量為700~4000之聚丙二醇 (1) Polypropylene glycol having a number average molecular weight of 700 to 4000

(2)數量平均分子量為700~4000之聚丙二醇與聚丁二醇之共聚物 (2) Copolymer of polypropylene glycol and polytetramethylene glycol having a number average molecular weight of 700 to 4000

(3)數量平均分子量為700~4000之聚丙二醇之衍生物(具體而言,數量平均分子量為700~4000之聚氧丙烯甘油醚、數量平均分子量為700~4000之聚氧丙烯山梨糖醇、數量平均分子量為700~4000之聚氧丙烯丁醚等) (3) a derivative of polypropylene glycol having a number average molecular weight of 700 to 4000 (specifically, a polyoxypropylene glyceryl ether having a number average molecular weight of 700 to 4000, a polyoxypropylene sorbitol having a number average molecular weight of 700 to 4000, a polyoxypropylene butyl ether having a number average molecular weight of 700 to 4000, etc.)

於本發明中,數量平均分子量可利用化妝品原料基準第二版註解I(1984年藥事日報社)之942頁中所記載之方法求出。 In the present invention, the number average molecular weight can be determined by the method described in 942 pages of the second edition of the Cosmetic Raw Materials Standards I (1984 Pharmaceutical Daily).

上述(1)~(3)之成分均可使用市售品。 Commercially available products can be used as the components of the above (1) to (3).

(1)作為數量平均分子量為700~4000之聚丙二醇,可較佳地使用數量平均分子量為1000之Newpol PP-1000(三洋化成工業股份有限公司)、數量平均分子量為2000之Newpol PP-2000(三洋化成工業股份有限公司)、數量平均分子量為4000之Newpol PP-4000(三洋化成工業股份有限公司)等。 (1) As the polypropylene glycol having a number average molecular weight of 700 to 4,000, Newpol PP-1000 (Sanyo Chemical Industry Co., Ltd.) having a number average molecular weight of 1,000 and Newpol PP-2000 having a number average molecular weight of 2000 can be preferably used. Sanyo Chemical Industry Co., Ltd.), Newpol PP-4000 (Sanyo Chemical Industry Co., Ltd.) with a number average molecular weight of 4,000.

(2)作為數量平均分子量為700~4000之聚丙二醇與聚丁二醇之共聚物,可較佳地使用數量平均分子量為700之PBG(polypropylene glycol)/PPG(polybutylene glycol)-9/1共聚物(聚丁二醇與聚丙二醇為9:1之共聚物。UNIOL PB-700,日本油脂股份有限公司)等。 (2) As a copolymer of polypropylene glycol and polytetramethylene glycol having a number average molecular weight of 700 to 4000, PBG (polypropylene glycol)/PPG (polybutylene glycol)-9/1 copolymer having a number average molecular weight of 700 can be preferably used. (a copolymer of polybutanediol and polypropylene glycol of 9:1. UNIOL PB-700, Nippon Oil & Fat Co., Ltd.) and the like.

(3)作為數量平均分子量為700~4000之聚丙二醇之衍生物,可較佳地使用聚氧丙烯甘油醚、聚氧丙烯山梨糖醇、聚氧丙烯丁醚等。 (3) As the derivative of polypropylene glycol having a number average molecular weight of 700 to 4,000, polyoxypropylene glyceryl ether, polyoxypropylene sorbitol, polyoxypropylene butyl ether or the like can be preferably used.

作為聚氧丙烯甘油醚,可較佳地使用數量平均分子量為1000之Newpol GP-1000(三洋化成工業股份有限公司)、數量平均分子量為4000之Newpol GP-4000(三洋化成工業股份有限公司)等。 As the polyoxypropylene glyceryl ether, Newpol GP-1000 (Sanyo Chemical Industry Co., Ltd.) having a number average molecular weight of 1,000, Newpol GP-4000 (Sanyo Chemical Industry Co., Ltd.) having a number average molecular weight of 4,000 or the like can be preferably used. .

又,作為聚氧丙烯山梨糖醇,可較佳地使用數量平均分子量為700之 Newpol SP-750(三洋化成工業股份有限公司)等。 Further, as the polyoxypropylene sorbitol, a number average molecular weight of 700 is preferably used. Newpol SP-750 (Sanyo Chemical Industry Co., Ltd.) and so on.

進而,作為聚氧丙烯丁醚,可較佳地使用數量平均分子量為1200之Newpol LB-285(三洋化成工業股份有限公司)、平均分子量為1870之Newpol LB-625(三洋化成工業股份有限公司)等。 Further, as the polyoxypropylene butyl ether, Newpol LB-285 (Sanyo Chemical Industry Co., Ltd.) having a number average molecular weight of 1,200 and Newpol LB-625 (Sanyo Chemical Industry Co., Ltd.) having an average molecular weight of 1,870 can be preferably used. Wait.

上述(1)~(3)之成分係於皮膚外用劑中通常作為保濕劑而調配之成分,但於本發明中發揮降低或防止擔載有銀之抗菌性磷酸三鈣粉末引起之泛白之效果,且作為泛白降低防止劑而調配之必須成分。 The components (1) to (3) are usually formulated as a moisturizing agent in the external preparation for skin, but in the present invention, the whitening effect caused by reducing or preventing the antibacterial tricalcium phosphate powder loaded with silver is exhibited. It is an essential component of the effect and is formulated as a whitening prevention agent.

<(B)數量平均分子量為700~4000之聚丙二醇、數量平均分子量為700~4000之聚丙二醇與聚丁二醇之共聚物或數量平均分子量為700~4000之聚丙二醇之衍生物之調配量> <(B) Polypropylene glycol having a number average molecular weight of 700 to 4000, a copolymer of polypropylene glycol and polytetramethylene glycol having a number average molecular weight of 700 to 4000, or a derivative of a polypropylene glycol derivative having a number average molecular weight of 700 to 4000 >

上述(B)成分之調配量相對於皮膚外用劑總量為0.1~20質量%,較佳為1~20質量%,進而較佳為5~20質量%。(B)成分之調配量可根據製品形態適當決定並調配適當之量。 The amount of the component (B) to be added is 0.1 to 20% by mass, preferably 1 to 20% by mass, and more preferably 5 to 20% by mass based on the total amount of the external preparation for skin. The blending amount of the component (B) can be appropriately determined according to the form of the product and blended in an appropriate amount.

於本發明之皮膚外用劑中,除上述必須成分以外,於無損本發明之效果之範圍內,可將通常化妝品或準藥品等皮膚外用劑中所調配之其他成分例如粉末成分、液體油脂、固體油脂、蠟、烴油、高級脂肪酸、高級醇、酯油、聚矽氧油、陰離子界面活性劑、陽離子界面活性劑、兩性界面活性劑、非離子界面活性劑、保濕劑、皮膜劑、紫外線吸收劑、金屬離子螫合劑、低級醇、多元醇、糖、胺基酸、有機胺、高分子乳液、pH值調整劑、皮膚營養劑、維他命、抗氧化劑、抗氧化助劑、香料、水等視需要適當調配,根據目標之劑型藉由常用方法而製造。 In addition to the above-mentioned essential components, other ingredients such as a powder component, a liquid fat, and a solid which are formulated in a skin external preparation such as a general cosmetic or a quasi-drug can be used in addition to the above-mentioned essential components. Oils, waxes, hydrocarbon oils, higher fatty acids, higher alcohols, ester oils, polyoxygenated oils, anionic surfactants, cationic surfactants, amphoteric surfactants, nonionic surfactants, humectants, coating agents, UV absorption Agent, metal ion chelating agent, lower alcohol, polyol, sugar, amino acid, organic amine, polymer emulsion, pH adjuster, skin nutrient, vitamin, antioxidant, antioxidant, fragrance, water, etc. It needs to be properly formulated and manufactured according to the target dosage form by a common method.

再者,本發明之劑型並不受限定,較佳為使擔載有銀之抗菌性磷酸三鈣粉末分散而成之液狀的皮膚外用劑。 Further, the dosage form of the present invention is not limited, and a liquid external preparation for skin which is obtained by dispersing an antibacterial tricalcium phosphate powder carrying silver is preferable.

尤其是就提高B成分之溶解性或者賦予清涼感或乾燥之速度之觀點而言,較佳為相對於皮膚外用劑總量而調配乙醇至少30質量%以上、較佳為 調配30質量%~95質量%之液狀之皮膚外用劑。 In particular, from the viewpoint of improving the solubility of the component B or imparting a cooling sensation or a speed of drying, it is preferred to blend at least 30% by mass or more with respect to the total amount of the external preparation for skin, preferably A liquid skin external preparation of 30% by mass to 95% by mass is formulated.

本發明之皮膚外用劑之製品形態並無特別限定。例如,較佳 為將擔載有銀之抗菌性磷酸三鈣粉末分散而成之液狀化妝料(1)填充至滾塗式容器中之防臭化妝料、(2)填充至氣溶膠式或分注器式容器中之霧狀防臭化妝料、(3)含浸於不織布等之片材中之片狀防臭化妝料等製品形態,該等製品可藉由常用方法而製造。 The form of the product for external use of the skin of the present invention is not particularly limited. For example, preferably A liquid cosmetic (1) in which a silver-loaded antibacterial tricalcium phosphate powder is dispersed is filled into a deodorant cosmetic in a roll-on container, and (2) is filled into an aerosol or dispenser container. The misty and deodorant cosmetic in the middle, and (3) the form of a product such as a sheet-like deodorant cosmetic which is impregnated into a sheet such as a non-woven fabric, and the like can be produced by a usual method.

除上述製品形態以外,粉末型、粉餅型、膏型等防臭化妝料可作為本發明之皮膚外用劑藉由常用方法而製造。 In addition to the above-mentioned product form, a deodorant cosmetic such as a powder type, a powder type, or a paste type can be produced as a skin external preparation of the present invention by a usual method.

實施例 Example

其次,列舉實施例對本發明進一步具體地進行說明。本發明並不受其限定。調配量只要無特別說明則為相對於總量之質量%。 Next, the present invention will be further specifically described by way of examples. The invention is not limited thereto. The blending amount is the mass % relative to the total amount unless otherwise specified.

以「表1」所示之配方藉由常用方法製造擔載有銀之抗菌性磷酸三鈣分散而成之液狀化妝料,藉由下述評價方法確認本發明之效果即塗佈後之泛白。 A liquid cosmetic prepared by dispersing silver-containing antibacterial tricalcium phosphate was prepared by a usual method in the formulation shown in "Table 1", and the effect of the present invention, that is, the coated pan, was confirmed by the following evaluation method. White.

「泛白防止之評價」 "Evaluation of Whitening Prevention"

利用微量吸管將「表1」~「表3」之皮膚外用劑10μL塗佈於黑色人工皮膚上之1.5cm×1.5cm之範圍。以目視確認兩小時後之泛白,利用以下基準進行評價。 10 μL of the skin external preparations of "Table 1" to "Table 3" were applied to a range of 1.5 cm × 1.5 cm on black artificial skin using a micropipette. The whitening after two hours was visually confirmed, and the evaluation was performed using the following criteria.

<評價基準> <Evaluation criteria>

◎:完全未看到泛白。 ◎: No whitening was seen at all.

○:可看到稍許泛白,但與比較例1相比泛白大幅度降低,在容許範圍內。 ○: A slight whitening was observed, but the whitening was greatly reduced as compared with Comparative Example 1, and was within the allowable range.

×:明確地看到泛白。 ×: Clearly see whitening.

「泛白之降低、防止效果」 "Reduce the whitening, prevent the effect"

用作上述所使用之B成分、B成分以外之各種保濕劑的市售品係如下所示。 Commercially available products which are used as various humectants other than the B component and the B component used above are as follows.

根據上述「表2」及「表3」之結果可知,本發明之實施例具有泛白之防止效果優異的效果。 According to the results of the above-mentioned "Table 2" and "Table 3", it is understood that the examples of the present invention have an effect of excellent whitening prevention effect.

與此相對地,調配聚丙二醇200、聚丙二醇400、POE-POP二甲醚等保濕劑來替代本發明之(B)成分的比較例並無泛白之防止效果。 On the other hand, a comparative example in which a humectant such as polypropylene glycol 200, polypropylene glycol 400 or POE-POP dimethyl ether was blended instead of the component (B) of the present invention did not have a whitening prevention effect.

以下,列舉本發明之皮膚外用劑之配方例。其泛白之降低、防止效果均優異。 Hereinafter, a formulation example of the external preparation for skin of the present invention will be listed. Its whitening is reduced and the prevention effect is excellent.

「配方例1:適於滾塗式容器之化妝料(液狀化妝料)」 "Recipe Example 1: Cosmetics for Roll-on Containers (Liquid Cosmetics)"

「配方例2:適於滾塗式容器之化妝料(液狀化妝料)」 "Recipe 2: Cosmetics suitable for roll-on containers (liquid cosmetics)"

「配方例3:可填充於氣溶膠式或分注器容器式中之霧狀防臭化妝料」 "Recipe 3: A misty and deodorant cosmetic that can be filled in an aerosol or dispenser container"

「配方例4:可含浸於片材中之片狀防臭化妝料」 "Formulation Example 4: A sheet-like deodorant cosmetic that can be immersed in a sheet"

[產業上之可利用性] [Industrial availability]

根據本發明,可提供一種調配有擔載有銀之抗菌性磷酸三鈣粉末,且降低或防止擔載有銀之抗菌性磷酸三鈣粉末引起之泛白的皮膚外用劑。 According to the present invention, it is possible to provide an external preparation for skin which is formulated with an antibacterial tricalcium phosphate powder carrying silver and which reduces or prevents whitening caused by the antibacterial tricalcium phosphate powder carrying silver.

Claims (6)

一種皮膚外用劑,含有:(A)擔載有銀之抗菌性磷酸三鈣,及(B)數量平均分子量為700~4000之聚丙二醇、數量平均分子量為700~4000之聚丙二醇與聚丁二醇之共聚物、或數量平均分子量為700~4000之聚丙二醇之衍生物中的任一者。 An external preparation for skin comprising: (A) an antibacterial tricalcium phosphate loaded with silver, and (B) a polypropylene glycol having a number average molecular weight of 700 to 4000, a polypropylene glycol having a number average molecular weight of 700 to 4000, and polybutane Any one of a copolymer of an alcohol or a derivative of a polypropylene glycol having a number average molecular weight of 700 to 4,000. 如申請專利範圍第1項之皮膚外用劑,其中上述(B)數量平均分子量為700~4000之聚丙二醇之衍生物為數量平均分子量為700~4000之聚氧丙烯甘油醚、數量平均分子量為700~4000之聚氧丙烯山梨糖醇、數量平均分子量為700~4000之聚氧丙烯丁醚中的任一者。 The skin external preparation according to Item 1 of the patent application, wherein the (B) derivative of polypropylene glycol having a number average molecular weight of 700 to 4000 is a polyoxypropylene glyceryl ether having a number average molecular weight of 700 to 4000, and a number average molecular weight of 700. Any of polyoxypropylene sorbitol of ~4000 and polyoxypropylene butyl ether of a number average molecular weight of 700-4000. 如申請專利範圍第1項或第2項之皮膚外用劑,其相對於皮膚外用劑總量,含有乙醇30質量%以上。 The skin external preparation according to Item 1 or Item 2 of the patent application contains 30% by mass or more of ethanol based on the total amount of the external preparation for skin. 如申請專利範圍第1項至第3項中任一項之皮膚外用劑,其為液狀化妝料,且為可填充於滾塗式容器中之防臭化妝料。 The skin external preparation according to any one of claims 1 to 3, which is a liquid cosmetic and is a deodorant cosmetic which can be filled in a roll-on type container. 如申請專利範圍第1項至第3項中任一項之皮膚外用劑,其為液狀化妝料,且為可填充於氣溶膠式或分注器式容器中之霧狀防臭化妝料。 The skin external preparation according to any one of claims 1 to 3, which is a liquid cosmetic and is a mist-like deodorant cosmetic which can be filled in an aerosol type or dispenser type container. 如申請專利範圍第1項至第3項中任一項之皮膚外用劑,其為液狀化妝料,且為含浸於片材中之片狀防臭化妝料。 The skin external preparation according to any one of claims 1 to 3, which is a liquid cosmetic and is a sheet-like deodorant cosmetic impregnated in a sheet.
TW102108994A 2012-03-15 2013-03-14 External preparation for skin TW201345558A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012058128A JP2013189409A (en) 2012-03-15 2012-03-15 Skin care preparation

Publications (1)

Publication Number Publication Date
TW201345558A true TW201345558A (en) 2013-11-16

Family

ID=49160809

Family Applications (1)

Application Number Title Priority Date Filing Date
TW102108994A TW201345558A (en) 2012-03-15 2013-03-14 External preparation for skin

Country Status (3)

Country Link
JP (1) JP2013189409A (en)
TW (1) TW201345558A (en)
WO (1) WO2013136890A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112016028513B1 (en) * 2014-06-23 2020-09-29 Rohm And Haas Company OIL FREE EMOLIENTS IN SUN PROTECTION COMPOSITIONS
BR112016028815A2 (en) * 2014-06-23 2017-08-22 Rohm & Haas oil-free emollients in personal care compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08126690A (en) * 1994-10-28 1996-05-21 Sangi Co Ltd Deodorant
JP4951785B2 (en) * 2004-04-13 2012-06-13 鈴木油脂工業株式会社 Antibacterial fine particles, process for producing the same, and cosmetics or fungicides containing the antibacterial fine particles
JP4889096B2 (en) * 2006-02-09 2012-02-29 株式会社 資生堂 Antibacterial zeolite and skin external preparation containing the same
JP5183090B2 (en) * 2006-04-28 2013-04-17 花王株式会社 Non-water based sweat deodorant stick composition
DE102009002371A1 (en) * 2009-04-15 2010-10-21 Evonik Goldschmidt Gmbh Process for the preparation of odorless polyether alcohols by means of DMC catalysts and their use in cosmetic and / or dermatological preparations

Also Published As

Publication number Publication date
JP2013189409A (en) 2013-09-26
WO2013136890A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
TWI605829B (en) Oil water emulsion sunscreen cosmetics
CN102348448A (en) Thickening additive compositions
WO2015146398A1 (en) Deodorant composition and deodorant agent
KR20110139527A (en) Self-preserving skin care formulation
JP5832118B2 (en) Powder-containing cosmetic
JP2007145771A (en) Antibacterial agent composition and deodorant agent
JP4959010B1 (en) Topical skin preparation
JP2007217394A (en) Pharmaceutical composition
TW201345558A (en) External preparation for skin
JP2006028084A (en) Deodorant and preparation
EP3445324A1 (en) Deodorant composition
JP6553394B2 (en) Liquid system sweat deodorant composition
JP4743704B2 (en) Antibacterial agent for bad odor bacteria, anti-odor agent and external preparation for skin containing the antibacterial agent
JPWO2016084615A1 (en) Liquid skin preparation
JP2007145750A (en) Antibacterial agent to osmidrosis bacterium, and osmidrosis-preventing agent and external preparation for skin, containing the antibacterial agent
CA2770621A1 (en) Liquid shaving preparation
WO2011149006A1 (en) Aqueous composition to be contained in container
JP5025535B2 (en) Antibacterial agent composition and deodorant composition
JP2011144146A (en) Gel-like bactericide for finger
JP2020002113A (en) Transparent composition
JP2006096719A (en) Deodorizing composition and deodorant preparation
JP6207324B2 (en) Skin cosmetics
JP7320614B2 (en) Skin topical agent
KR101803976B1 (en) Multipurpose Cleaning Composition Having Nanoemulsion Forms
JP5483820B2 (en) Antibacterial composition and deodorant